Yvonne Esq - Schrodinger Chief Secretary
| SDGR Stock | USD 20.84 0.47 2.31% |
Executive
Yvonne Esq is Chief Secretary of Schrodinger
| Age | 53 |
| Address | 1540 Broadway, New York, NY, United States, 10036 |
| Phone | 212 295 5800 |
| Web | https://www.schrodinger.com |
Schrodinger Management Efficiency
The company has return on total asset (ROA) of (0.1864) % which means that it has lost $0.1864 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3506) %, meaning that it created substantial loss on money invested by shareholders. Schrodinger's management efficiency ratios could be used to measure how well Schrodinger manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Schrodinger's Return On Tangible Assets are relatively stable compared to the past year. As of 11/22/2024, Return On Assets is likely to grow to 0.05, while Return On Capital Employed is likely to drop (0.28). At this time, Schrodinger's Non Current Assets Total are relatively stable compared to the past year. As of 11/22/2024, Intangible Assets is likely to grow to about 5 M, while Net Tangible Assets are likely to drop slightly above 259.1 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sheila MBA | Certara | N/A | |
| Jim Goodrich | 10X Genomics | N/A | |
| Cassie Corneau | 10X Genomics | N/A | |
| MS MD | GE HealthCare Technologies | 52 | |
| Cheryl King | HealthEquity | N/A | |
| David Strickle | R1 RCM Inc | N/A | |
| Daniel Corcoran | Certara | N/A | |
| Colin McHugh | Accolade | 45 | |
| MD MBA | Accolade | N/A | |
| Rana Strellis | GE HealthCare Technologies | N/A | |
| Kathy Weiler | American Well Corp | 54 | |
| Jens Durruthy | 10X Genomics | N/A | |
| Vivian Welsh | Veeva Systems Class | N/A | |
| Drew Garner | Accolade | N/A | |
| Alexander Wong | 10X Genomics | N/A | |
| Steve Lindsay | HealthEquity | N/A | |
| Michael Waters | Teladoc | 51 | |
| Adam JD | Teladoc | 49 | |
| Richard Putnam | HealthEquity | N/A | |
| Cassandra Pratt | Progyny | N/A | |
| Katie Higgins | Progyny | N/A | |
Management Performance
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.19 |
Schrodinger Leadership Team
Elected by the shareholders, the Schrodinger's board of directors comprises two types of representatives: Schrodinger inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Schrodinger. The board's role is to monitor Schrodinger's management team and ensure that shareholders' interests are well served. Schrodinger's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Schrodinger's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kenneth Lorton, Executive CTO | ||
| Yvonne Esq, Chief Secretary | ||
| Ramy Farid, President CEO | ||
| Jenny Herman, Senior Controller | ||
| Karen Akinsanya, President Therapeutics | ||
| Shane Brauner, Executive Officer | ||
| Geoffrey MBBS, Executive CFO | ||
| Paul Davie, Executive Sales | ||
| Jaren Madden, Senior Communications | ||
| Pr III, CoFounder Advisor | ||
| Margaret MD, Chief Officer | ||
| Robert Abel, Chief Science | ||
| Richard Friesner, Scientific CoFounder |
Schrodinger Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Schrodinger a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.92) % | ||||
| Operating Margin | (1.94) % | ||||
| Current Valuation | 1.22 B | ||||
| Shares Outstanding | 63.69 M | ||||
| Shares Owned By Insiders | 2.39 % | ||||
| Shares Owned By Institutions | 96.12 % | ||||
| Number Of Shares Shorted | 8.9 M | ||||
| Price To Book | 3.30 X |
Pair Trading with Schrodinger
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Schrodinger position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Schrodinger will appreciate offsetting losses from the drop in the long position's value.Moving together with Schrodinger Stock
Moving against Schrodinger Stock
The ability to find closely correlated positions to Schrodinger could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Schrodinger when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Schrodinger - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Schrodinger to buy it.
The correlation of Schrodinger is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Schrodinger moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Schrodinger moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Schrodinger can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Schrodinger Stock Analysis
When running Schrodinger's price analysis, check to measure Schrodinger's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Schrodinger is operating at the current time. Most of Schrodinger's value examination focuses on studying past and present price action to predict the probability of Schrodinger's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Schrodinger's price. Additionally, you may evaluate how the addition of Schrodinger to your portfolios can decrease your overall portfolio volatility.